| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |